An open-label, single-arm phase two trial of gefitinib in patients with advanced or metastatic castration-resistant prostate cancer.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Guy Toner Michael J. Boyer Howard Gurney |
| Publication date | August 1, 2009 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |